Pharmacy Management

Pharmacy Management

Prescription drugs are the fastest growing component of healthcare costs. These costs can be prohibitive, requiring employers to change plan designs and shift even more cost to their employees. This is particularly true for specialty medications that typically represent 50% of drug spend from just 1-2% of drug utilizers. 

Unfortunately, many employers don’t have the purchasing power or market leverage to negotiate better pricing. It’s also challenging for employers to identify and access money saving opportunities. 

Our Alera Group Pharmacy Solutions practice has a dedicated team of experienced, in-house Pharmacy Benefits Management experts. They offer a full range of pharmacy consulting services, including:

  • Prescription drug program evaluations for clients of all sizes and industries
  • Comprehensive RFP management renewal, market check and RFI
  • PBM contract review and negotiation
  • Consultative support to identify and deploy unique cost-mitigation for specialty drug solutions
  • Data analytics that enable precise financial and clinical pharmacy benefits consulting and reporting, maximizing the plan value and employee dollars
  • All forms of pharmacy benefits auditing, including PBM contract pricing, plan design and clinical
  • On-going risk management and cost containment under our Rx Concierge Program

With Alera Group, you have a local partner and a team of experts you can rely on to help you manage pharmacy costs and improve your outcomes today and in the future.

Our Alera Group Pharmacy Solutions experts are backed by leading-edge tools and strategic solutions focused on meeting the needs and expectations of our clients through every stage of the pharmacy process.

Control pharmacy costs

From procurement to prescriptions.

Report Image
Download Now

Find an office or contact us

EXPERT EDUCATION

Events and Webinars

Employee Benefits

When Captive Insurance Makes Sense

In this session, our experts will talk about how captives work, the advantages and disadvantages and what you need to know to determine whether they make sense for your organization.

November 21, 2024 at 01:00 pm CT | Virtual

Sign Up
Webinar Graphic - Alera Engage

Employee Benefits

Q4 Compliance Update

Alera Group's quarterly employee benefits compliance roundup will help you stay current on the latest national regulatory developments impacting employers.

December 3, 2024 at 01:00 pm CT | Virtual

Sign Up
Webinar graphic - Alera Engage

THOUGHT LEADERSHIP

Insights

Employee Benefits

Webinar: Meeting the Needs of an Aging Workforce

Why is recognizing and addressing the priorities of older workers an imperative? Because, as Bain’s analysis of U.S. Bureau of Labor Statistics data determined, workers 55 and older will exceed a quarter of the workforce among G7 nations, including the United States, by 2031. Older workers typically have different priorities and needs compared to their younger colleagues, as Alera Group will examine and discuss on October 17 during the next event in our Engage series of employee benefits webinars, “Meeting the Needs of an Aging Workforce.”

October 3, 2024

Find out more

Employee Benefits

Wellbeing Fair Sessions — When and Where You Like

Themed “Live for Tomorrow,” Alera Group's 2024 Employee Wellbeing Fair is now available online, where you can access all eight sessions, select which ones you want to view and watch them at your convenience.

October 2, 2024

Find out more

Employee Benefits

Legal Alert: RxDC Reporting Due June 1

Reminder: RxDC Reporting Due June 1

With the 2023 reference year RxDC reporting deadline approaching soon, plan sponsors should familiarize themselves with recent updates to the RxDC Reporting Instructions.

March 27, 2024

Find out more

Employee Benefits

Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group

Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.

February 6, 2024

Find out more